Medicinal Cannabis Industry Australia (MCIA) is offering Cannabiz members an exclusive 20% discount off tickets to the association’s ACannabis EVOLVE conference taking place on March 16 and 17.
Moving to a virtual format this year, the event will offer all the benefits of a face-to-face conference including an unprecedented line up of national and international industry experts, networking opportunities, exhibition hall and virtual delegate bag.
Sessions will also be available to watch on-demand for 30 days after the event.
International speakers include Dr David Meiri (Technion, Israel), Professor Cherry L Wainwright (Robert Gordon University, Scotland), Professor Mike Dixon (University of Guelph, Canada), Sally King (New Zealand Medical Cannabis Council) and Keith Strachan (MediPharm Labs, Canada).
Also joining the program are Federal Minister for Health Greg Hunt, the TGA’s Professor John Skerritt, Professor Iain McGregor from the Lambert Initiative for Cannabinoid Therapeutics and chair of the Medicinal Cannabis Health Advisory Council and former Federal Green Party leader Richard Di Natale.
Company bosses include LeafCann Group CEO Elisabetta Faenza, Entoura general manager and global business development executive Clare Barker, Cannatrek head of R&D Emily Rigby and AusCann CEO Nick Woolf.
A session moderated by Cannabiz editor-at-large Rhys Cohen will hear leading experts from Australia, Canada, New Zealand and Europe share the latest trends, regulations and opportunities shaping the medicinal cannabis sector globally.
Epilepsy Action Australia CEO and MD Carol Ireland will chair a roundtable with health industry experts, patient advocates, doctors and researchers discussing the crucial role of education and training, patient advocacy and communication in enabling improved patient access.
And FreshLeaf Analytics MD Cassandra Hunt will give delegates an exclusive peek at the market intelligence company’s Q1 2021 report on the Australian cannabis landscape.
MCIA chair Peter Crock said: “It’s important to provide an opportunity to bring together all facets of the medicinal cannabis industry ecosystem to connect, engage and build a framework to support patients’ well-being, enable best practice, and support industry growth.
“Now more than ever we need to stay connected and we are thrilled to do this via an innovative virtual platform. Going virtual also means we can provide greater access for industry members from around Australia and globally to attend.”